EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study

Takuhisa Nukaya iD, Kiyoshi Takahara iD, Shingo Toyoda, Lan Inoki, Wataru Fukuokaya iD, Keiichiro Mori iD, Takehiro Iwata iD, Kensuke Bekku iD, Ryoichi Maenosono iD, Takuya Tsujino, Yosuke Hirasawa iD, Takafumi Yanagisawa und 6 weitere

International Journal of Urology · 2025

DOI: 10.1111/iju.70207 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Urology, 2025. Verfasst von Takuhisa Nukaya und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fujita-Health University School of Medicine, Toyoake, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Cytoreduction Surgical Procedures, Immune Checkpoint Inhibitors, Kidney Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We aimed to evaluate overall survival (OS) and determine the optimal timing of cytoreductive nephrectomy (CN) in patients with metastatic renal cell carcinoma (mRCC) receiving immune checkpoint inhibitor (ICI)‐based therapy.

Methods

This retrospective study reviewed medical records of 447 patients with mRCC treated with ICI at multiple Japanese institutions between January 2018 and August 2023. From this cohort, 178 patients with lymph node or distant metastases received either cytoreductive nephrectomy (CN group; n = 72) or ICI therapy without cytoreductive nephrectomy (non‐CN group; n = 106) as first‐line treatment.

Results

Median progression‐free survival was 15.7 months, and median overall survival was 58.1 months. CN significantly improved OS, with the CN group's median OS not reached, compared to 29.6 months in the non‐CN group ( p = 0.01). Deferred CN also showed improved survival outcomes. Poor prognostic factors for immediate CN included International Metastatic Renal Cell Carcinoma Database Consortium poor risk, sarcomatoid differentiation, and a high neutrophil‐to‐lymphocyte ratio.

Conclusions

We developed a prognostic model to guide patient selection for CN, emphasizing the need for personalized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellCytoreduction Surgical ProceduresImmune Checkpoint InhibitorsKidney NeoplasmsNephrectomyAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedJapanPatient SelectionPrognosisProgression-Free SurvivalRetrospective StudiesTime Factors

Stichwörter der Autor:innen

IMDC classificationcytoreductive nephrectomyimmune checkpoint inhibitorneutrophil‐to‐lymphocyte ratiosarcomatoid differentiation

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Urology, Fujita-Health University School of Medicine, Toyoake, Japan.
  • Department of Urology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Urology, Okayama University Graduate School of Medicine, Okayama, Japan.
  • Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Department of Urology, Tokyo Medical University, Tokyo, Japan.

ORCID-Profile: Takuhisa Nukaya, Kiyoshi Takahara, Wataru Fukuokaya, Keiichiro Mori, Takehiro Iwata, Kensuke Bekku, Ryoichi Maenosono, Yosuke Hirasawa, Motoo Araki, Yoshio Ohno

Zitieren

APA

Nukaya, T., Takahara, K., Toyoda, S., Inoki, L., Fukuokaya, W., Mori, K., Iwata, T., Bekku, K., Maenosono, R., Tsujino, T., Hirasawa, Y., Yanagisawa, T., Hashimoto, T., Komura, K., Araki, M., Fujita, K., Ohno, Y., & Shiroki, R. (2025). Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study. International Journal of Urology. https://doi.org/10.1111/iju.70207

Vancouver

Nukaya T, Takahara K, Toyoda S, Inoki L, Fukuokaya W, Mori K, et al. Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study. International Journal of Urology. 2025. doi:10.1111/iju.70207

BibTeX
@article{Nukaya2025,
  author = {Nukaya, Takuhisa and Takahara, Kiyoshi and Toyoda, Shingo and Inoki, Lan and Fukuokaya, Wataru and Mori, Keiichiro and Iwata, Takehiro and Bekku, Kensuke and Maenosono, Ryoichi and Tsujino, Takuya and Hirasawa, Yosuke and Yanagisawa, Takafumi and Hashimoto, Takeshi and Komura, Kazumasa and Araki, Motoo and Fujita, Kazutoshi and Ohno, Yoshio and Shiroki, Ryoichi},
  title = {Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study},
  journal = {International Journal of Urology},
  year = {2025},
  doi = {10.1111/iju.70207}
}
Kostenlos starten →